Source: Market Cheetah

ChipCare: CORRECTING and REPLACING ChipCare Retains Biotech Alliances International to Lead Series B Capital Raise

TORONTO-(BUSINESS WIRE)-ChipCare Retains Biotech Alliances International Life Sciences Investment Bank to Lead $18.8M Series B Capital Raise Source: BusinessWire-Primary CORRECTING and REPLACING ChipCare Retains Biotech Alliances International to Lead Series B Capital Raise Follow @marketcheetah

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
James Fraser's photo - CEO of ChipCare

CEO

James Fraser

CEO Approval Rating

73/100

Read more